Enovis CORP ENOV

Latest FY: 2025 Healthcare Medical Devices
Market Price $26.08
Market Cap $1.48B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.7% YoY
$2.25B
3-Yr CAGR: 12.9%
Net Income ↓-43.5% YoY
-$1.18B
Net Margin: -52.7%
Free Cash Flow ↑129.6% YoY
$19.92M
FCF Yield: 1.35%
EPS (Diluted) ↓-39.0% YoY
$-20.75
Basic: $-20.75
Return on Equity Efficiency
-79.5%
ROA: -98.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ENOV)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $3,647.0M $1,145.7M $128.1M $1.04 $247.0M $183.7M
FY 2017 $3,300.2M -9.5% $1,029.5M $151.1M +17.9% $1.22 +17.3% $218.8M $150.0M -18.4%
FY 2018 $2,193.1M -33.5% $729.4M $140.2M -7.2% $1.16 -4.9% $226.4M $156.7M +4.5%
FY 2019 $3,327.5M +51.7% $1,401.1M $-527.6M -476.4% $-3.89 -435.3% $130.9M $5.5M -96.5%
FY 2020 $3,070.8M -7.7% $1,288.1M $42.6M +108.1% $0.31 +108.0% $301.9M $187.2M +3,274.5%
FY 2021 $3,854.3M +25.5% $1,613.7M $71.7M +68.1% $0.46 +48.4% $356.1M $251.9M +34.6%
FY 2022 $1,563.1M -59.4% $869.4M $-13.3M -118.5% $-0.25 -154.3% $-55.9M $-161.3M -164.0%
FY 2023 $1,707.2M +9.2% $990.8M $-33.3M -150.2% $-0.61 -144.0% $135.0M $12.8M +107.9%
FY 2024 $2,107.6M +23.5% $1,180.8M $-825.5M -2,381.9% $-14.93 -2,347.5% $113.5M $-67.2M -626.5%
FY 2025 $2,248.0M +6.7% $1,345.3M $-1,184.4M -43.5% $-20.75 -39.0% $217.3M $19.9M +129.6%
$

Valuation

Market Price $26.08
Market Cap $1.48B
Enterprise Value $2.74B
P/E Ratio N/A
P/B Ratio 1.01
FCF Yield 1.35%
Dividend Yield N/A
Shares Outstanding 57,562,600
%

Profitability & Margins

Gross Margin 59.84%
Operating Margin -50.01%
Net Margin -52.69%
Return on Equity (ROE) -79.51%
Return on Assets (ROA) -98.13%
Asset Turnover 1.86x
Revenue 3-Yr CAGR 12.88%
🛡️

Financial Health & Liquidity

Current Ratio 3.21
Cash Ratio 0.10
Debt / Equity 0.871
Debt / Assets 1.074
Cash & Equivalents $36.39M
Total Debt $1.30B
Book Value / Share $25.88
💧

Cash Flow Efficiency

Operating Cash Flow $217.29M
Capital Expenditures (CapEx) $197.38M
Free Cash Flow $19.92M
OCF / Revenue 9.67%
FCF / Revenue 0.89%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-20.75
EPS (Basic) $-20.75
Dividends / Share N/A
Book Value / Share $25.88
EPS YoY Growth -38.98%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.21B
Total Liabilities $375.94M
Stockholders' Equity $1.49B
Current Assets $1.21B
Current Liabilities $375.94M